GSK press releases Follow Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B First global approval for Hibsago https://www.gsk.com/en-gb/media/press-releases/hibsago-bepirovirsen-approved-in-japan-as-first-and-only-functional-cure-for-chronic-hepatitis-b/ gsk.com
